Sensydia
PrivateLast Round
Grant
Jun 9, 2025
Total Funding Raised
$7.4M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Sensydia is a healthcare technology company that develops a portable, point-of-care hemodynamic measurement device for the treatment and management of heart disease patients, facilitating non-invasive monitoring of critical cardiac metrics to enhance patient outcomes and reduce healthcare costs.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Health IoT, Sensors
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sensydia Comparables
Compare Sensydia with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Acorai | 88% | |
| Respirix, Inc. | 82% | |
| NI Medical | 80% |
Sensydia Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 9, 2025 | ||||
| Grant | Jun 5, 2023 | ||||
| VC Round | May 9, 2023 | ||||
| Series B | Jan 19, 2022 | ||||
| VC Round | Jul 23, 2020 | ||||
Series B | Jul 18, 2017 |
Key People
Founding team and executive leadership
Sensydia Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| Colle Capital | VC Round, Series B |
| Orlando Health Ventures | VC Round |
| National Heart, Lung, and Blood Institute | Grant |
| Frontier Venture Capital | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Monthly visitors increased 41% MoM.
- Apr 19, 2026
Monthly visitors grew 43% MoM, reaching 3.4K.
Sensydia Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Sensydia's valuation, stock price, and market status.
Is Sensydia a public or private company?
Sensydia is a private company.
What is the current stock price of Sensydia?
Sensydia is a private company with no public stock price. No recent secondary market data is available.
How much is Sensydia worth (valuation)?
Valuation information for Sensydia is not publicly available.
Can I buy Sensydia stock?
Sensydia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Sensydia's last funding round?
Sensydia's most recent funding round was Grant on June 5, 2023.
Who are the main investors in Sensydia?
Key investors in Sensydia include Colle Capital, Orlando Health Ventures.
Will Sensydia IPO soon?
No public IPO plans have been announced for Sensydia.
How can I track Sensydia secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Sensydia's secondary market activity and sign up for updates.